Dr Kim Orchard trained in medicine at the Royal Free Hospital London after completing a degree in Microbiology and Virology at the University of Warwick. He obtained a PhD for basic research into the transcriptional control of HIV performed at the Chester Beatty Laboratories, Institute of Cancer Research, London.
After completing training in Haematology at the Royal Free and Hammersmith Hospitals he returned to the Royal Free to establish a clinical research programme in targeted radiotherapy. He was appointed as a Senior Lecturer and Consultant Haematologist in Southampton in 2001. He has a specialist interest in Haemato-oncology particularly the use of haematopoietic stem cell transplantation in the treatment of haematological malignancies such as myeloma, acute and chronic leukaemias. Research interests are in the manipulation of transplant conditioning protocols with the aim of improving outcomes, both by reducing the toxicity of transplant conditioning and reducing the risk of relapse post transplantation. He has been actively investigating the use of radiolabelled antibodies as part of the preparative conditioning protocols prior to transplantation for several years and currently has phase I and II clinical trials open in several UK sites. He is also interested in post-transplant immunotherapy which includes the use of donor lymphocyte infusions to reduce relapse and to improve immune reconstitution.